Sonoma Private Wealth LLC Sells 45 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sonoma Private Wealth LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,552 shares of the healthcare conglomerate’s stock after selling 45 shares during the period. UnitedHealth Group accounts for approximately 1.4% of Sonoma Private Wealth LLC’s portfolio, making the stock its 20th largest position. Sonoma Private Wealth LLC’s holdings in UnitedHealth Group were worth $907,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth about $27,000. Macroview Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares during the period. Delos Wealth Advisors LLC boosted its position in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $31,000. Finally, Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $2.64 during trading hours on Friday, reaching $568.67. The stock had a trading volume of 829,910 shares, compared to its average volume of 3,952,345. The firm has a market cap of $525.12 billion, a price-to-earnings ratio of 37.53, a PEG ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The firm has a 50-day moving average of $584.20 and a 200-day moving average of $533.07. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the business earned $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 55.70%.

Analyst Ratings Changes

A number of research firms have recently commented on UNH. KeyCorp initiated coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target on the stock. Cantor Fitzgerald raised their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday. Stephens cut their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday. UBS Group lowered their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $615.16.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.